-
Blurred Lines: When Similar Symptoms Can Mean Different Things
7 min read
Latest News
-
Anti-nausea drug helps cells with the HD mutation stay healthy in a surprising way
4 min read
Anti-nausea drug meclizine protects cells with the HD mutation from death by reducing cellular energy production
-
HDBuzz takes your questions to the annual therapeutics meeting of CHDI
4 min read
HDBuzz visits Palm Springs to talk with CHDI about the latest HD research. Send us your questions!
-
Welcome to HDBuzz
3 min read
Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co
-
Memantine in HD: dose is everything
4 min read
Memantine, a drug already used in Alzheimer’s disease, might help in HD, but a mouse study shows dose is everything.
-
An active lifestyle may make a difference to HD symptoms
4 min read
More reasons to be active: a passive lifestyle may contribute to earlier onset of symptoms in HD.
-
Frequently asked questions, January 2011
5 min read
Answers to frequently-asked questions about HD – the first in a regular series of HDBuzz FAQ articles.
-
Getting the data out – a new scientific journal just for HD
4 min read
New scientific journal PLoS Currents HD promises rapid publication & open access, improving scientific communication
-
Dimebon: disappointing in Alzheimer’s but might work in HD
3 min read
Dimebon – disappointing results in an Alzheimer’s disease trial, but hope remains for HD.
-
Does HD cause brains to develop differently?
4 min read
Smaller total brain volumes in male HD mutation carriers suggests brain development may be different in HD.
-
Is Huntington’s disease twice as common as we thought?
5 min read
New data suggest there may be twice as many people with HD symptoms as previously thought – and even more at risk
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
